Chemotherapy-induced neuropathy is a common, dose-dependent adverse effect of several
antineoplastics. It can lead to detrimental dose reductions and discontinuation of treatment …

Peripheral neuropathy is one of the most common side effects of chemotherapy, affecting up
to 60% of all cancer patients receiving chemotherapy. Moreover, paclitaxel induces …

Chemotherapy induced peripheral neuropathy (CIPN) is a potentially dose limiting side
effect of commonly used chemotherapeutic agents like taxanes, vinca-alkaloids, platinum …

The peripheral nervous system can be vulnerable to the toxic action of several drugs since it
is not protected as effectively as the central nervous system from noxious exogenous agents …

Background The objective of this study was to systematically review all available literature
concerning chemotherapy-induced peripheral neuropathy (CIPN) and quality of life (QOL) …

Chemotherapy induced peripheral neuropathy (CIPN) is a type of neuropathic pain that is a
major dose-limiting side-effect of potentially curative cancer chemotherapy treatment …

When peripheral neuropathy occurs due to chemotherapy treatment, it is referred to as
chemotherapy-induced peripheral neuropathy (CIPN). Typically, symptoms are sensory …

The experience of pain in cancer is widely accepted as a major threat to quality of life, and
the relief of pain has emerged as a priority in oncology care. Pain is associated with both the …

Vincristine-induced peripheral neuropathy (VIPN) is a dose-limiting side effect of vincristine
(VCR) treatment in children, leading to diminished quality of life. Much remains unknown …

Neuronal networks, especially those in the central nervous system (CNS), evolved to
support extensive functional capabilities while ensuring stability. Several physiological …